SENSEX NIFTY
You are here : Moneycontrol > Markets > Share/Stock Price > Pharmaceuticals > Hikal

Hikal

BSE: 524735 | NSE: HIKAL | ISIN: INE475B01022 | SECTOR: PHARMACEUTICALS
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Apr 27, 17:00
139.60
0.00 (0.00%)
VOLUME 3,269
AVERAGE VOLUME
5-Day 2,003
10-Day 2,999
30-Day 5,065
VOLUME SHOCKER
5-Day 2,003
10-Day 2,999
30-Day 5,065
Prev. Close
139.60
Open Price
139.40
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
0.00 (0)
Today’s Low/High 133.00 143.60
52 Wk Low/High 117.00 835.00
LIVE
NSE
Apr 28, 09:17
138.00
-0.70 (-0.50%)
VOLUME 145
AVERAGE VOLUME
5-Day 10,903
10-Day 14,269
30-Day 23,596
VOLUME SHOCKER
5-Day 10,903
10-Day 14,269
30-Day 23,596
Prev. Close
138.70
Open Price
138.00
Bid PRICE (QTY.)
137.00 (1)
Offer PRICE (Qty.)
138.70 (122)
Today’s Low/High 138.00 138.00
52 Wk Low/High 115.15 836.75

No recommendations so far.

What's your call on Hikal today?
Read 4 investor views

Consolidated
MARKET CAP (Rs Cr)
1,147.52
P/E
34.38
BOOK VALUE (Rs)
48.52
DIV (%)
45.00%
Market Lot
1
INDUSTRY P/E
26.99
EPS (TTM)
4.06
P/C
12.97
PRICE/BOOK
2.88
DIV YIELD.(%)
0.64%
FACE VALUE (Rs)
2.00
DELIVERABLES (%)
59.66 new
DELIVERY AVERAGES
3-Day 59.99%
5-Day 60.00%
8-Day 62.79%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Hikal on the go with moneycontrol app
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

27 April 2015

sell

HUL Apr Fut

Entry Price (Rs)

873.00

Exit Price (Rs)

866.00

Gain (Rs)

7.00

sell

Larsen Apr Fut

Entry Price (Rs)

1,676.00

Exit Price (Rs)

1,662.00

Gain (Rs)

14.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 101.01 139.40  
High Price 102.00 143.60  
Low Price 97.60 133.00  
Last Price 99.15 139.60 40.80
Volume 32,920 3,269 -90.07
Simple Moving Averages
Days BSE NSE
30 138.88 139.45
50 140.92 141.24
150 144.49 144.75
200 138.31 138.57

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Hikal

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Dec'14 Sep'14 Jun'14
Mar'14
Net Sales 225.05 242.88 190.39 227.54
Other Income 0.20 0.35 0.83 0.32
PBDIT 47.59 53.59 36.28 51.49
Net Profit 9.37 15.25 5.70 3.07

Annual Report

Download in PDF format 2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'14
(In Rs Cr)
Total Share Capital 16.44
Net Worth 505.91
Total Debt 470.37
Net Block 644.14
Investments 3.13
Total Assets 976.28
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 922.40 -0.47 1200.70 586.90 221,940.57
Lupin 1694.00 -1.67 2112.00 928.80 76,143.32
Dr Reddys Labs 3339.00 -1.24 3808.75 2250.00 56,890.27
Cipla 620.00 -1.35 752.45 385.00 49,783.55
Ranbaxy Labs 859.90 0.00 869.00 414.40 36,602.80
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Sep' 14Jun' 14Dec' 13Sep' 13
Promoter68.7768.7768.8368.83
FII4.654.553.203.20
DII9.508.909.828.76
Others17.0817.7818.1519.21
Total100.00100.00100.00100.00
Company Information
REGISTERED OFFICE
Address
717/718, Maker Chambers V,,Nariman Point
City
Mumbai
State
Maharashtra
Pin Code
400021
Tel. No.
022-27574276
Fax No.
022-27574277
REGISTRARS
Name
Universal Capital Securities Pvt. Ltd.
Address
21/25, Shakil Nivas, Opp. Satya Saibaba Temple, Mahakali Caves Road, Andheri (East)
City
Mumbai - 400093
State
Maharashtra
Tel. No.
022-28207203, 28207204, 28207205, 28257641
Fax No.
022-28262920, 28267207
MANAGEMENT
Name
Designation
Jai Hiremath
Chairman & Managing Director
Sameer Hiremath
Joint Managing Director
Suguna Ravichandran
Independent Director
C G Kumar
Independent Director
Baba Kalyani
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Pondy Oxides Recommended on Jan 6th 2015

Recommended price 47.00  |  Peak from reco 76.55 61.84%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Hikal

Hikal is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,147.52 crore.

The company management includes Jai Hiremath - Chairman & Managing Director, Sameer Hiremath - Joint Managing Director, Suguna Ravichandran - Independent Director, C G Kumar - Independent Director, Baba Kalyani - Director, Prakash Mehta - Director, Shivkumar Kheny - Director, Kannan Unni - Director, Peter Pollak - Director, Amit Kalyani - Director, Wolfgang Welter - Director, Sugandha Hiremath - Director, Axel Kleemann - Additional Director.

It is listed on the BSE with a BSE Code of 524735 and the NSE with an NSE Code of HIKAL.

Its Registered office is at 717/718, Maker Chambers V,,Nariman Point Mumbai,Maharashtra - 400021.

Their Registrars are Universal Capital Securities Pvt. Ltd.

Quick Links for Hikal
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Hikal